Related Experiment Video

Updated: Aug 16, 2026

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy

Richard T Hinkle1, Elizabeth Dolan, David B Cody

  • 1Research Division, Procter & Gamble Pharmaceuticals, Health Care Research Center, 8700 Mason-Montgomery Road, Mason, Ohio 45040, USA.

Muscle & Nerve
|August 24, 2005
PubMed

Insights

Inhibiting phosphodiesterase 4 (PDE 4) can prevent muscle loss. PDE 4 inhibitors may treat skeletal muscle-wasting diseases by modulating cyclic adenosine monophosphate (cAMP) levels.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Physiology

Background:

  • G-protein-coupled receptors activating Galphas increase skeletal muscle mass.
  • The cyclic adenosine monophosphate (cAMP) pathway is implicated in muscle mass regulation.

Purpose of the Study:

  • To investigate the role of the cAMP pathway in skeletal muscle mass regulation.
  • To evaluate phosphodiesterase 4 (PDE 4) inhibitors as modulators of skeletal muscle cAMP levels.

Main Methods:

  • Utilized PDE 4 inhibitors to modulate cAMP levels in skeletal muscle.
  • Assessed the effects of PDE 4 inhibition on muscle mass and force loss in denervated and casted rodents (rats and mice).

Main Results:

  • PDE 4 inhibitors significantly reduced muscle mass loss.
  • PDE 4 inhibitors attenuated the loss of muscle force.
  • Modulation of skeletal muscle cAMP levels by PDE 4 inhibitors showed protective effects.

Conclusions:

  • PDE 4 inhibitors demonstrate potential therapeutic value for skeletal muscle-wasting conditions.
  • Targeting the cAMP pathway via PDE 4 inhibition offers a promising strategy for preserving muscle mass and function.

More Related Videos

Myo-mechanical Analysis of Isolated Skeletal Muscle08:42

Myo-mechanical Analysis of Isolated Skeletal Muscle

Published on: February 22, 2011

Freezing Injury in Mouse Masseter Muscle to Establish an Orofacial Muscle Fibrosis Model06:33

Freezing Injury in Mouse Masseter Muscle to Establish an Orofacial Muscle Fibrosis Model

Published on: December 29, 2023

Related Concept Videos

Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...